1997
DOI: 10.1002/(sici)1097-0142(19971215)80:12+<2699::aid-cncr48>3.0.co;2-4
|View full text |Cite
|
Sign up to set email alerts
|

Pretargeting using peptide nucleic acid

Abstract: can adversely influence localization when these molecules are used.F. Chang, Ph.D.METHODS. As RESULTS.In both the infection and tumor mouse models, increased localization of radiolabel was achieved in animals receiving both injectates compared with control animals receiving only the radiolabeled PNA. In the infection model, the infected to normal thigh radioactivity ratio was 3.5 for the study animals compared with 1.7 for control animals (P Å 0.0001). In the tumor model, these values were 1.7 versus 1.2 (P… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
47
0

Year Published

2001
2001
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 61 publications
(49 citation statements)
references
References 7 publications
1
47
0
Order By: Relevance
“…PNAs, however, are not well distributed in vivo (Rusckowski et al, 1997). For a PNA-based anti-telomerase therapeutic to succeed, the pharmocokinetics and toxicology of PNA would need to be optimized in tandem with surmounting the considerable challenges presented by telomerase as a target.…”
Section: Telomerase As a Target For Oligonucleotidesmentioning
confidence: 99%
“…PNAs, however, are not well distributed in vivo (Rusckowski et al, 1997). For a PNA-based anti-telomerase therapeutic to succeed, the pharmocokinetics and toxicology of PNA would need to be optimized in tandem with surmounting the considerable challenges presented by telomerase as a target.…”
Section: Telomerase As a Target For Oligonucleotidesmentioning
confidence: 99%
“…137 An interesting alternative approach for the use of radioactive PNA probes for therapeutic purposes deserves to be mentioned in this perspective. In the so-called "pretargeting using PNA" developed by Hnatowich et al, 120,127,128 a single-stranded PNA bound to a protein/antibody -which binds, for example, specifically to receptors over-expressed in cancer cells -is administered first into an animal or human, followed by admission of the complementary single-stranded radiolabeled PNA. This technique provides sufficient time for the protein-PNA conjugate to find its target and, for the excess of the construct, to be cleared from circulation and other tissues.…”
Section: Metal-containing Pnas As Radioactive Probesmentioning
confidence: 99%
“…This technique provides sufficient time for the protein-PNA conjugate to find its target and, for the excess of the construct, to be cleared from circulation and other tissues. 120 Nonetheless, there have been, to the best of our knowledge, no other reports since the three papers of Hnatowich and co-workers despite the huge potential and fascinating perspectives of this concept.…”
Section: Metal-containing Pnas As Radioactive Probesmentioning
confidence: 99%
“…19,31,[40][41][42][43][44] For the purpose of this work, we decided to use a di-(2-picolyl)amide (Dpam) derivative (3, Figure 1) as a coordination entity for Re/ 99m…”
Section: Mmentioning
confidence: 99%